All News #Library
Biotech
Organovo Updates Cash and Nasdaq Listing Requirements
02 Apr 2025 //
GLOBENEWSWIRE
Organovo Sells FXR Program to Eli Lilly and Company
25 Mar 2025 //
GLOBENEWSWIRE
Organovo Issues Additional Shares With Warrant Exercises
06 Mar 2025 //
GLOBENEWSWIRE
Organovo`s FXR Program, including FXR314, Acquired by Eli Lilly
25 Feb 2025 //
GLOBENEWSWIRE
Organovo Announces Appointment of Norman as CFO
06 Jan 2025 //
GLOBENEWSWIRE
Organovo Presents FXR314 Data In Phase 2 MASH At The Liver Meeting
20 Nov 2024 //
GLOBENEWSWIRE
Organovo to Present FXR314 Clinical Data at Liver Meeting
13 Nov 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support